147 related articles for article (PubMed ID: 38909824)
1. Advances in cytokine-based herbal medicine against premature ovarian insufficiency: A review.
Siyu Y; Shixiao Z; Congying S; Xinqin Z; Zhen H; Xiaoying W
J Ethnopharmacol; 2024 Jun; 333():118477. PubMed ID: 38909824
[TBL] [Abstract][Full Text] [Related]
2. Plasma-derived from human umbilical cord blood restores ovarian function and improves serum reproductive hormones levels in mice with premature ovarian insufficiency (POI) through cytokines and growth factors.
Sun TC; Guo YM; Li DM; Wen YJ; Jiao ZX; Li J; Wang HP; Jia YJ; Zhou SJ
Mol Reprod Dev; 2024 Feb; 91(2):e23731. PubMed ID: 38404010
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency.
Cao Y; Chen Y; Wang P; Lu J; Han X; She J
Bioengineered; 2021 Dec; 12(2):10345-10362. PubMed ID: 34753385
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic drug targets and pathways prediction for premature ovarian insufficiency -Based on network pharmacologic method.
Ju S; He J; Wang H; Yang L; Guo A; Guo Y; Qi M; Wang H; Ai L
J Ethnopharmacol; 2023 Mar; 304():116054. PubMed ID: 36526095
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the efficacy of the use of acupuncture and Chinese herbal medicine for the treatment of premature ovarian insufficiency (POI): A systematic review and metaanalysis.
Li HF; Zhang JX; Chen WJ
Heliyon; 2023 Oct; 9(10):e20498. PubMed ID: 37818004
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic profiles and inflammatory markers in Premature Ovarian Insufficiency.
Kunicki M; Rzewuska N; Gross-Kępińska K
J Reprod Immunol; 2024 May; 164():104253. PubMed ID: 38776714
[TBL] [Abstract][Full Text] [Related]
7. Gui ShenWan prevent premature ovarian insufficiency by modulating autophagy and angiogenesis via facilitating VDR.
Zhou M; Niu H; Chen R; Chen W; Cui D
J Ethnopharmacol; 2024 May; 326():117955. PubMed ID: 38395181
[TBL] [Abstract][Full Text] [Related]
8. Bushen Huoxue recipe ameliorates ovarian function via promoting BMSCs proliferation and homing to ovaries in POI mice.
Huang Y; Hu R; Liu Z; Geng Y; Li F; Song Y; Ma W; Dong H; Xu L; Zhang M; Song K
Phytomedicine; 2024 Jul; 129():155630. PubMed ID: 38678952
[TBL] [Abstract][Full Text] [Related]
9. Zigui-Yichong-Fang protects against cyclophosphamide-induced premature ovarian insufficiency via the SIRT1/Foxo3a pathway.
Xiu Z; Tang S; Kong P; Yan M; Tong X; Liu X; Liang X; Li R; Duan Y
J Ethnopharmacol; 2023 Oct; 314():116608. PubMed ID: 37150421
[TBL] [Abstract][Full Text] [Related]
10. TNF-α and IFN-γ prestimulation enhances the therapeutic efficacy of human amniotic epithelial stem cells in chemotherapy-induced ovarian dysfunction.
Huang Y; Zhang Q; Cao W; Zhang Q; Wang L; Lai D
Inflamm Regen; 2023 Nov; 43(1):57. PubMed ID: 37993924
[TBL] [Abstract][Full Text] [Related]
11. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.
Ling L; Feng X; Wei T; Wang Y; Wang Y; Wang Z; Tang D; Luo Y; Xiong Z
Stem Cell Res Ther; 2019 Jan; 10(1):46. PubMed ID: 30683144
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in women with primary ovarian insufficiency: a scoping review of the literature and implications for targeted interventions.
McDonald IR; Welt CK; Dwyer AA
Hum Reprod; 2022 Nov; 37(12):2817-2830. PubMed ID: 36102839
[TBL] [Abstract][Full Text] [Related]
13. Paracrine effects of human amniotic epithelial cells protect against chemotherapy-induced ovarian damage.
Zhang Q; Bu S; Sun J; Xu M; Yao X; He K; Lai D
Stem Cell Res Ther; 2017 Nov; 8(1):270. PubMed ID: 29179771
[TBL] [Abstract][Full Text] [Related]
14. Kuntai capsule attenuates premature ovarian insufficiency by activating the FOXO3/SIRT5 signaling pathway in mice: A comprehensive study using UHPLC-LTQ-Orbitrap and integrated pharmacology.
Gong L; Hou J; Yang H; Zhang X; Zhao J; Wang L; Yin X; Feng X; Yin C
J Ethnopharmacol; 2024 Mar; 322():117625. PubMed ID: 38145859
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic mechanism of premature ovarian failure and rescue effect of Traditional Chinese Medicine: a review.
Cai L; Zong DK; Tong GQ; Li L
J Tradit Chin Med; 2021 Jun; 41(3):492-498. PubMed ID: 34114409
[TBL] [Abstract][Full Text] [Related]
16. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
[TBL] [Abstract][Full Text] [Related]
17. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis.
Li M; Zhu Y; Wei J; Chen L; Chen S; Lai D
Climacteric; 2023 Apr; 26(2):95-102. PubMed ID: 36519275
[TBL] [Abstract][Full Text] [Related]
18. The effect of Bu Shen Huo Xue Tang on autoimmune premature ovarian insufficiency via Modulation of the Nrf2/Keap1 signaling pathway in mice.
Chen S; Lu Y; Chen Y; Xu J; Chen L; Zhao W; Wang T; Wang H; Wang P
J Ethnopharmacol; 2021 Jun; 273():113996. PubMed ID: 33684516
[TBL] [Abstract][Full Text] [Related]
19. Chinese herbal medicine for premature ovarian insufficiency: A protocol for systematic review.
Shao Y; Zhou H; Zhou M; Ying P; Yao Z; Jiang X
Medicine (Baltimore); 2020 Mar; 99(11):e19371. PubMed ID: 32176060
[TBL] [Abstract][Full Text] [Related]
20. Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation.
Ahmadian S; Sheshpari S; Pazhang M; Bedate AM; Beheshti R; Abbasi MM; Nouri M; Rahbarghazi R; Mahdipour M
Reprod Biol Endocrinol; 2020 Aug; 18(1):78. PubMed ID: 32758249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
